Long-acting growth hormone releasing factor analog for advanced peptide research.

CJC-1295 w/DAC is a modified growth hormone releasing factor analog studied extensively in endocrine and peptide signaling research models. The addition of DAC technology provides extended activity characteristics that continue to make this compound highly relevant within modern research environments.

Azyrion Labs CJC-1295 w/DAC is developed using rigorous quality standards intended to support advanced scientific research applications.

Research Attributes

• Extended-activity peptide analog
• Precision-formulated research compound
• Laboratory-focused manufacturing standards
• Premium vial presentation

Storage

Store under refrigerated conditions away from direct sunlight.